The global paediatric spasticity treatment industry is expected to reach growing at a CAGR of 10% from 2022 to 2032. Paediatric spasticity is a condition characterized by increased muscle tone and stiffness, which can make it difficult for children to move and perform everyday activities. The market is driven by a number of factors, including …